Modelled DT Structure
Method: homology modeling
Template PDB: 4XPH_A
Identity: 46.972%
Minimized Score: -1472.193 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0445 | ||||
| Gene Name | SLC6A13 | ||||
| Protein Name | Sodium- and chloride-dependent GABA transporter 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 4XPH_A Identity: 46.972% Minimized Score: -1472.193 kcal/mol Detail: Structure Info |
||||
| Synonyms | GAT-2; GAT2; SLC6A13; Solute carrier family 6 member 13 | ||||
| DT Family | Neurotransmitter:Sodium Symporter (NSS) Family ; | ||||
| Tissue Specificity | Expressed in brain, kidney, lung, liver andtestis. | ||||
| Function | This sodium-dependent transporter is for GABA and taurine and may also be involved in beta-alanine transport. In presynaptic terminals, regulates GABA signaling termination through GABA uptake. | ||||
| Endogenous Substrate(s) | Cl-; Gamma-aminobutyric acid; Na+ | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Beta-alanine
|
Phase 4 | Drug Info | Muscle function | VC01 | [1] |
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| Gamma-aminobutyric acid | EM Info | Identified using SLC6A6 knockout DLD-1 and HeLa cells | [2] | ||
| References | |||||
| 1 | Astrocytic -aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain. 2018 Feb;113:1-7. | ||||
| 2 | Neurotransmitter transporter family including SLC6A6 and SLC6A13 contributes to the 5-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin IX and photodamage, through uptake of ALA by cancerous cells. Photochem Photobiol. 2014 Sep-Oct;90(5):1136-43. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.